anmelden
FTSE All-Share
5.572,14
PKT
+30,90
PKT
+0,56
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.06.18 | HSBC Neutral | Goldman Sachs Group Inc. | |
| 04.06.18 | Shell (ex Royal Dutch Shell) Hold | HSBC | |
| 04.06.18 | Shell (ex Royal Dutch Shell) Hold | HSBC | |
| 04.06.18 | BP buy | HSBC | |
| 04.06.18 | BP Outperform | Bernstein Research | |
| 04.06.18 | Shell (ex Royal Dutch Shell) Outperform | Bernstein Research | |
| 04.06.18 | Lloyds Banking Group overweight | JP Morgan Chase & Co. | |
| 01.06.18 | Unilever Outperform | BNP PARIBAS | |
| 01.06.18 | Unilever Outperform | BNP PARIBAS | |
| 01.06.18 | BAT buy | Jefferies & Company Inc. | |
| 01.06.18 | National Grid Hold | Deutsche Bank AG | |
| 31.05.18 | Barclays Neutral | Goldman Sachs Group Inc. | |
| 31.05.18 | Lloyds Banking Group Sell | Goldman Sachs Group Inc. | |
| 31.05.18 | HSBC Neutral | Goldman Sachs Group Inc. | |
| 31.05.18 | Diageo overweight | JP Morgan Chase & Co. | |
| 31.05.18 | Unilever Neutral | JP Morgan Chase & Co. | |
| 31.05.18 | Unilever Neutral | JP Morgan Chase & Co. | |
| 31.05.18 | Imperial Brands Neutral | JP Morgan Chase & Co. | |
| 31.05.18 | BAT overweight | JP Morgan Chase & Co. | |
| 31.05.18 | GSK Neutral | JP Morgan Chase & Co. | |
| 31.05.18 | National Grid overweight | JP Morgan Chase & Co. | |
| 30.05.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 30.05.18 | Lloyds Banking Group Outperform | Credit Suisse Group | |
| 29.05.18 | National Grid overweight | Morgan Stanley | |
| 29.05.18 | BP buy | Goldman Sachs Group Inc. | |
| 29.05.18 | Diageo Outperform | Credit Suisse Group | |
| 29.05.18 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 28.05.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 25.05.18 | Imperial Brands overweight | Barclays Capital | |
| 25.05.18 | Imperial Brands overweight | Barclays Capital | |
| 25.05.18 | Diageo buy | Citigroup Corp. | |
| 25.05.18 | GSK buy | UBS AG | |
| 25.05.18 | Prudential buy | Deutsche Bank AG | |
| 25.05.18 | Imperial Brands Sector Perform | RBC Capital Markets | |
| 25.05.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 24.05.18 | Rio Tinto Outperform | Macquarie Research | |
| 24.05.18 | Vodafone Group buy | UBS AG | |
| 24.05.18 | AstraZeneca Hold | S&P Capital IQ | |
| 23.05.18 | Barclays Neutral | Goldman Sachs Group Inc. | |
| 23.05.18 | Marks Spencer Neutral | UBS AG |